Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Carisma’s lifeline disappears as reverse merger plans break down
The walls are closing in even tighter for Carisma as reverse merger plans fall through and Moderna cuts ties.
Gabrielle Masson
Sep 18, 2025 10:40am
Biogen inks $85M Alcyone buyout to acquire drug delivery tech
Sep 18, 2025 10:30am
VectorY pens $1.2B pact to use Shape's brain-penetrating capsid
Sep 18, 2025 9:25am
Roche becomes MASH player via $3.5B deal for 89bio, ph. 3 drug
Sep 18, 2025 5:02am
US VC launches another biotech with China-licensed asset
Sep 17, 2025 10:30am
CSL pays $117M for option on phase 3 blood clotting specialist
Sep 16, 2025 4:31am
